List of Tables
    Table 1. Anti - Neoplastic Agents CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
    Table 2. Anti - Neoplastic Agents Market Trends
    Table 3. Anti - Neoplastic Agents Market Drivers
    Table 4. Anti - Neoplastic Agents Market Challenges
    Table 5. Anti - Neoplastic Agents Market Restraints
    Table 6. Global Anti - Neoplastic Agents Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Anti - Neoplastic Agents Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Anti - Neoplastic Agents Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Anti - Neoplastic Agents Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Anti - Neoplastic Agents Manufacturers in Global Market, Ranking by Revenue (2021)
    Table 11. Global Anti - Neoplastic Agents Revenue by Manufacturer, (US$ Million), 2017-2022
    Table 12. Global Anti - Neoplastic Agents Revenue Share by Manufacturer, 2017-2022
    Table 13. Global Anti - Neoplastic Agents Sales by Manufacturer, (K Units), 2017-2022
    Table 14. Global Anti - Neoplastic Agents Sales Share by Manufacturer, 2017-2022
    Table 15. Global Anti - Neoplastic Agents Price by Manufacturer (2017-2022) & (USD/Unit)
    Table 16. Global Anti - Neoplastic Agents Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Anti - Neoplastic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti - Neoplastic Agents as of 2021)
    Table 18. Top Players of Anti - Neoplastic Agents in Global Market, Headquarters and Distribution of Producing Region
    Table 19. Manufacturers Anti - Neoplastic Agents Product Type
    Table 20. Date of International Manufacturers Enter into Anti - Neoplastic Agents Market
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Top Anti - Neoplastic Agents Players in United States Market, Ranking by Revenue (2021)
    Table 23. United States Anti - Neoplastic Agents Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 24. United States Anti - Neoplastic Agents Revenue Share by Players, 2020, 2021 & 2022
    Table 25. United States Anti - Neoplastic Agents Sales by Players, (K Units), 2020, 2021 & 2022
    Table 26. United States Anti - Neoplastic Agents Sales Share by Players, 2020, 2021 & 2022
    Table 27. Global Anti - Neoplastic Agents Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 28. Global Anti - Neoplastic Agents Sales in Volume by Region (2017-2022) & (K Units)
    Table 29. Global Anti - Neoplastic Agents Sales in Volume Forecast by Region (2023-2028) & (K Units)
    Table 30. Global Anti - Neoplastic Agents Sales in Value by Region (2017-2022) & (US$ Million)
    Table 31. Global Anti - Neoplastic Agents Sales in Value Forecast by Region (2023-2028) & (US$ Million)
    Table 32. North America Anti - Neoplastic Agents Sales in Volume by Country (2017-2028) & (K Units)
    Table 33. North America Anti - Neoplastic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 34. Asia Pacific Anti - Neoplastic Agents Sales in Volume by Region (2017-2028) & (K Units)
    Table 35. Asia Pacific Anti - Neoplastic Agents Sales in Value by Region (2017-2028) & (US$ Million)
    Table 36. Europe Anti - Neoplastic Agents Sales in Volume by Country (2017-2028) & (K Units)
    Table 37. Europe Anti - Neoplastic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 38. Latin America Anti - Neoplastic Agents Sales in Volume by Country (2017-2028) & (K Units)
    Table 39. Latin Americaa Anti - Neoplastic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 40. Middle East and Africa Anti - Neoplastic Agents Sales in Volume by Country (2017-2028) & (K Units)
    Table 41. Middle East and Africa Anti - Neoplastic Agents Sales in Value by Country (2017-2028) & (US$ Million)
    Table 42. Roche Corporation Information
    Table 43. Roche Description and Business Overview
    Table 44. Roche Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 45. Roche Anti - Neoplastic Agents Product
    Table 46. Roche Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Novartis Product
    Table 51. Novartis Recent Development
    Table 52. Celgene Corporation Information
    Table 53. Celgene Description and Business Overview
    Table 54. Celgene Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 55. Celgene Product
    Table 56. Celgene Recent Development
    Table 57. Bristol-Myers Squibb Corporation Information
    Table 58. Bristol-Myers Squibb Description and Business Overview
    Table 59. Bristol-Myers Squibb Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 60. Bristol-Myers Squibb Product
    Table 61. Bristol-Myers Squibb Recent Development
    Table 62. Amgen Corporation Information
    Table 63. Amgen Description and Business Overview
    Table 64. Amgen Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 65. Amgen Product
    Table 66. Amgen Recent Development
    Table 67. Johnson & Johnson Corporation Information
    Table 68. Johnson & Johnson Description and Business Overview
    Table 69. Johnson & Johnson Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 70. Johnson & Johnson Product
    Table 71. Johnson & Johnson Recent Development
    Table 72. Pfizer Corporation Information
    Table 73. Pfizer Description and Business Overview
    Table 74. Pfizer Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 75. Pfizer Product
    Table 76. Pfizer Recent Development
    Table 77. Takeda Corporation Information
    Table 78. Takeda Description and Business Overview
    Table 79. Takeda Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Takeda Product
    Table 81. Takeda Recent Development
    Table 82. Eli Lilly Corporation Information
    Table 83. Eli Lilly Description and Business Overview
    Table 84. Eli Lilly Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 85. Eli Lilly Product
    Table 86. Eli Lilly Recent Development
    Table 87. AstraZeneca Corporation Information
    Table 88. AstraZeneca Description and Business Overview
    Table 89. AstraZeneca Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 90. AstraZeneca Product
    Table 91. AstraZeneca Recent Development
    Table 92. Astellas Corporation Information
    Table 93. Astellas Description and Business Overview
    Table 94. Astellas Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 95. Astellas Product
    Table 96. Astellas Recent Development
    Table 97. Merck & Co. Corporation Information
    Table 98. Merck & Co. Description and Business Overview
    Table 99. Merck & Co. Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 100. Merck & Co. Product
    Table 101. Merck & Co. Recent Development
    Table 102. Sanofi Corporation Information
    Table 103. Sanofi Description and Business Overview
    Table 104. Sanofi Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 105. Sanofi Product
    Table 106. Sanofi Recent Development
    Table 107. Bayer Corporation Information
    Table 108. Bayer Description and Business Overview
    Table 109. Bayer Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Bayer Product
    Table 111. Bayer Recent Development
    Table 112. Biogen Idec Corporation Information
    Table 113. Biogen Idec Description and Business Overview
    Table 114. Biogen Idec Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Biogen Idec Product
    Table 116. Biogen Idec Recent Development
    Table 117. Eisai Corporation Information
    Table 118. Eisai Description and Business Overview
    Table 119. Eisai Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Eisai Product
    Table 121. Eisai Recent Development
    Table 122. Teva Corporation Information
    Table 123. Teva Description and Business Overview
    Table 124. Teva Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Teva Product
    Table 126. Teva Recent Development
    Table 127. Otsuka Corporation Information
    Table 128. Otsuka Description and Business Overview
    Table 129. Otsuka Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Otsuka Product
    Table 131. Otsuka Recent Development
    Table 132. Merck KGaA Corporation Information
    Table 133. Merck KGaA Description and Business Overview
    Table 134. Merck KGaA Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Merck KGaA Product
    Table 136. Merck KGaA Recent Development
    Table 137. Ipsen Corporation Information
    Table 138. Ipsen Description and Business Overview
    Table 139. Ipsen Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Ipsen Product
    Table 141. Ipsen Recent Development
    Table 142. AbbVie Corporation Information
    Table 143. AbbVie Description and Business Overview
    Table 144. AbbVie Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. AbbVie Product
    Table 146. AbbVie Recent Development
    Table 147. Gilead Sciences Corporation Information
    Table 148. Gilead Sciences Description and Business Overview
    Table 149. Gilead Sciences Anti - Neoplastic Agents Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. Gilead Sciences Product
    Table 151. Gilead Sciences Recent Development
    Table 152. Key Raw Materials Lists
    Table 153. Raw Materials Key Suppliers Lists
    Table 154. Anti - Neoplastic Agents Customers List
    Table 155. Anti - Neoplastic Agents Distributors List
    Table 156. Research Programs/Design for This Report
    Table 157. Key Data Information from Secondary Sources
    Table 158. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti - Neoplastic Agents Product Picture
    Figure 2. Global Anti - Neoplastic Agents Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Anti - Neoplastic Agents Market Size 2017-2028 (US$ Million)
    Figure 4. Global Anti - Neoplastic Agents Sales 2017-2028 (K Units)
    Figure 5. United States Anti - Neoplastic Agents Revenue, (US$ Million), 2017 VS 2022 VS 2028
    Figure 6. United States Anti - Neoplastic Agents Market Size 2017-2028 (US$ Million)
    Figure 7. United States Anti - Neoplastic Agents Sales 2017-2028 (K Units)
    Figure 8. United States Anti - Neoplastic Agents Market Share in Global, in Value (US$ Million) 2017-2028
    Figure 9. United States Anti - Neoplastic Agents Market Share in Global, in Volume (K Units) 2017-2028
    Figure 10. Anti - Neoplastic Agents Report Years Considered
    Figure 11. Product Picture of Chemotherapy
    Figure 12. Product Picture of Targeted Therapy
    Figure 13. Product Picture of Immunotherapy
    Figure 14. Product Picture of Hormonal Therapy(Biologic Therapy)
    Figure 15. Product Picture of Others
    Figure 16. Global Anti - Neoplastic Agents Market Share by Type in 2022 & 2028
    Figure 17. Global Anti - Neoplastic Agents Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 18. Global Anti - Neoplastic Agents Sales Market Share in Value by Type (2017-2028)
    Figure 19. Global Anti - Neoplastic Agents Sales by Type (2017-2028) & (K Units)
    Figure 20. Global Anti - Neoplastic Agents Sales Market Share in Volume by Type (2017-2028)
    Figure 21. Global Anti - Neoplastic Agents Price by Type (2017-2028) & (USD/Unit)
    Figure 22. United States Anti - Neoplastic Agents Market Share by Type in 2022 & 2028
    Figure 23. United States Anti - Neoplastic Agents Sales in Value by Type (2017-2028) & (US$ Million)
    Figure 24. United States Anti - Neoplastic Agents Sales Market Share in Value by Type (2017-2028)
    Figure 25. United States Anti - Neoplastic Agents Sales by Type (2017-2028) & (K Units)
    Figure 26. United States Anti - Neoplastic Agents Sales Market Share in Volume by Type (2017-2028)
    Figure 27. United States Anti - Neoplastic Agents Price by Type (2017-2028) & (USD/Unit)
    Figure 28. Product Picture of Blood Cancer
    Figure 29. Product Picture of Breast Cancer
    Figure 30. Product Picture of Gastrointestinal Cancer
    Figure 31. Product Picture of Prostate Cancer
    Figure 32. Product Picture of Respiratory/Lung Cancer
    Figure 33. Product Picture of Other Cancers
    Figure 34. Global Anti - Neoplastic Agents Market Share by Application in 2022 & 2028
    Figure 35. Global Anti - Neoplastic Agents Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 36. Global Anti - Neoplastic Agents Sales Market Share in Value by Application (2017-2028)
    Figure 37. Global Anti - Neoplastic Agents Sales by Application (2017-2028) & (K Units)
    Figure 38. Global Anti - Neoplastic Agents Sales Market Share in Volume by Application (2017-2028)
    Figure 39. Global Anti - Neoplastic Agents Price by Application (2017-2028) & (USD/Unit)
    Figure 40. United States Anti - Neoplastic Agents Market Share by Application in 2022 & 2028
    Figure 41. United States Anti - Neoplastic Agents Sales in Value by Application (2017-2028) & (US$ Million)
    Figure 42. United States Anti - Neoplastic Agents Sales Market Share in Value by Application (2017-2028)
    Figure 43. United States Anti - Neoplastic Agents Sales by Application (2017-2028) & (K Units)
    Figure 44. United States Anti - Neoplastic Agents Sales Market Share in Volume by Application (2017-2028)
    Figure 45. United States Anti - Neoplastic Agents Price by Application (2017-2028) & (USD/Unit)
    Figure 46. North America Anti - Neoplastic Agents Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 47. North America Anti - Neoplastic Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 48. U.S. Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Canada Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Europe Anti - Neoplastic Agents Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 51. Europe Anti - Neoplastic Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 52. Germany Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 53. France Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.K. Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Italy Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Russia Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Asia-Pacific Anti - Neoplastic Agents Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 58. Asia-Pacific Anti - Neoplastic Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 59. China Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 60. Japan Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 61. South Korea Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 62. India Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 63. Australia Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 64. Taiwan Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 65. Indonesia Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 66. Thailand Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 67. Malaysia Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 68. Philippines Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 69. Latin America Anti - Neoplastic Agents Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 70. Latin America Anti - Neoplastic Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 71. Mexico Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 72. Brazil Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 73. Argentina Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 74. Middle East & Africa Anti - Neoplastic Agents Sales in Volume Growth Rate 2017-2028 (K Units)
    Figure 75. Middle East & Africa Anti - Neoplastic Agents Sales in Value Growth Rate 2017-2028 (US$ Million)
    Figure 76. Turkey Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 77. Saudi Arabia Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 78. U.A.E Anti - Neoplastic Agents Sales in Value Growth Rate (2017-2028) & (US$ Million)
    Figure 79. Anti - Neoplastic Agents Value Chain
    Figure 80. Anti - Neoplastic Agents Production Process
    Figure 81. Channels of Distribution
    Figure 82. Distributors Profiles
    Figure 83. Bottom-up and Top-down Approaches for This Report
    Figure 84. Data Triangulation
    Figure 85. Key Executives Interviewed